Do Biodegradable Polymers Have an Advantage? - Michael Joner, MD

↳ This is a section part of Moment: CRT 2015 Technology & Innovation - Biodegradable Polymers DES Programs

Add this Moment to your Passport

Learn from this moment and keep it forever.

Add To Passport

$15.99

This moment is included in Simple Premium - Get started for free.

FREE with Simple Premium

Start your 30-day free trial

Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Preview

Summary

Do Biodegradable Polymers Have an Advantage? presented by Michael Joner, MD at CRT 2015

Add this Moment to your Passport

Learn from this moment and keep it forever.

Add To Passport

$15.99

This moment is included in Simple Premium - Get started for free.

FREE with Simple Premium

Start your 30-day free trial

Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Target Audience

Interventional Cardiologists
Interventional Fellows
Physicians with an interest in Cardiovascular Innovations

Session Name: Biodegradable Polymers DES Programs

Track: Technology & Innovation

Learning Objectives

Updates in the latest Cardiovascular Innovations

Other Components in this Moment

Do Biodegradable Polymers Have an Advantage? - Michael Joner, MD

Does the Clinical Data Support the Use of DES with Biodegradable Polymers Over DES with Durable Polymers? - R. A. Byrne, MB BCh PhD

EXCELLA Novolimus Elution from PLLA Polymer-Coated Stents - Ricardo Costa, MD, PhD

Three-year Clinical Update on MiStent SES - Alexandra J. Lansky, MD

EVOLVE II In-Depth - Ian T. Meredith, MD, PhD

Orsiro: PLLA/Sirolimus Biodegradable: The Bioflow Studies in Depth - Ron Waksman, MD

Combo: A Combination of Sirolimus-Eluting Biodegradable Polymer and Anti-CD34 Antibody Coated Stent - Mitchell W. Krucoff, MD

OCT Findings of Biodegradable Polymeric Stents (The Timeless Study) - Juan F. Granada, MD

Loading Simple Education